KANSAS CITY, Kan. and NEW YORK, Jan. 2, 2013 /PRNewswire/ -- Aratana Therapeutics, an animal health company developing innovative medicines for cats and dogs (companion animals), announced today that president and CEO Steven St. Peter, M.D. will be presenting at the Biotech Showcase 2013 Conference being held in San FranciscoJanuary 7-9, 2013. Dr. St. Peter will provide an overview of the company's companion animal medicine programs and development strategy.
Details of Aratana's presentation are as follows:
Biotech Showcase 2013 Conference
Tuesday, January 8, 2013
Hearst room; Parc 55 Wyndham San Francisco Union Square Hotel
Co-produced by EBD Group and Demy-Colton Life Science Advisors, Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences.
About Aratana Therapeutics
Aratana Therapeutics is an animal health drug development company uniquely positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals). Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market. For more information, please visit www.aratanatherapeutics.com.
For Investors & Media:
Joshua Drumm, Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
SOURCE Aratana Therapeutics